Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 59.95x is 29% above its estimated 5-year average of 46.54x, around the middle of its estimated 5-year range (0.32x–184.79x).
As of 2026-10-06T19:50:50.577Z. 11.90% above its estimated 12-month average of 53.58x.
Calculation as of: 2026-10-06T19:50:50.577Z.
Quote observation: 2026-10-06T19:50:43.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f621ea2a381ac0066d385c57ed104ff22630177ee14cd635e65ed0429d7856c2
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
59.95x
EV/SALES RATIO AVG TTM
53.58x
EV/SALES RATIO AVG 3Y
8.40x
EV/SALES RATIO AVG 5Y
46.54x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+11.90%
CURRENT VS 3Y AVG
+614.08%
CURRENT VS 5Y AVG
+28.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.36x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+1275.00%
vs the sector median at left
Aclaris Therapeutics, Inc.
Market Cap
$511.87M
EV/Sales Ratio
59.95x
TTM Avg
53.58x
3Y Avg
8.40x
5Y Avg
46.54x
Market Cap
$518.27M
EV/Sales Ratio
15837.72x
TTM Avg
12786.98x
3Y Avg
8694.17x
5Y Avg
5938.95x
Market Cap
$498.45M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$501.07M
EV/Sales Ratio
27.85x
TTM Avg
23.82x
3Y Avg
1214.34x
5Y Avg
954.66x
Market Cap
$505.65M
EV/Sales Ratio
115.81x
TTM Avg
137.79x
3Y Avg
11402.18x
5Y Avg
6462.77x
Market Cap
$498.72M
EV/Sales Ratio
1.27x
TTM Avg
1.59x
3Y Avg
1.25x
5Y Avg
1.40x
Market Cap
$528.14M
EV/Sales Ratio
5.06x
TTM Avg
4.75x
3Y Avg
15.43x
5Y Avg
15.84x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | $511.87M | 59.95x | 53.58x | 8.40x | 46.54x |
| Altimmune, Inc. (ALT)vs › | $518.27M | 15837.72x | 12786.98x | 8694.17x | 5938.95x |
| 908 Devices Inc. (MASS)vs › | $504.02M | 7.32x | 3.81x | 2.66x | 4.57x |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $498.45M | N/A | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $501.07M | 27.85x | 23.82x | 1214.34x | 954.66x |
| Allogene Therapeutics, Inc. (ALLO)vs › | $505.65M | 115.81x | 137.79x | 11402.18x | 6462.77x |
| Tactile Systems Technology, Inc. (TCMD)vs › | $498.72M | 1.27x | 1.59x | 1.25x | 1.40x |
| Immix Biopharma, Inc. (IMMX)vs › | $524.09M | N/A | N/A | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $528.14M | 5.06x | 4.75x | 15.43x | 15.84x |
| Nuvectis Pharma, Inc. (NVCT)vs › | $530.73M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 71.82x |
| 2026-10-02 | 73.91x |
| 2026-10-01 | 74.26x |
| 2026-09-30 | 89.02x |
| 2026-09-29 | 89.36x |
| 2026-09-28 | 91.97x |
| 2026-09-25 | 87.11x |
| 2026-09-24 | 91.10x |
| 2026-09-23 | 89.02x |
| 2026-09-22 | 97.01x |
| 2026-09-21 | 94.40x |
| 2026-09-18 | 93.18x |
| 2026-09-17 | 91.45x |
| 2026-09-16 | 90.06x |
| 2026-09-15 | 93.71x |
| 2026-09-14 | 95.62x |
| 2026-09-11 | 90.06x |
| 2026-09-10 | 93.36x |
| 2026-09-09 | 94.23x |
| 2026-09-08 | 102.91x |
| 2026-09-04 | 104.82x |
| 2026-09-03 | 101.00x |
| 2026-09-02 | 104.99x |
| 2026-09-01 | 102.22x |
| 2026-08-31 | 102.74x |
| 2026-08-28 | 102.04x |
| 2026-08-27 | 104.65x |
| 2026-08-26 | 105.17x |
| 2026-08-25 | 111.25x |
| 2026-08-24 | 107.25x |
| 2026-08-21 | 108.99x |
| 2026-08-20 | 107.60x |
| 2026-08-19 | 109.51x |
| 2026-08-18 | 107.25x |
| 2026-08-17 | 100.48x |
| 2026-08-14 | 98.05x |
| 2026-08-13 | 99.44x |
| 2026-08-12 | 99.09x |
| 2026-08-11 | 100.48x |
| 2026-08-10 | 100.13x |
| 2026-08-07 | 100.31x |
| 2026-08-06 | 90.57x |
| 2026-08-05 | 94.72x |
| 2026-08-04 | 88.87x |
| 2026-08-03 | 81.95x |
| 2026-07-31 | 76.87x |
| 2026-07-30 | 78.71x |
| 2026-07-29 | 75.63x |
| 2026-07-28 | 78.87x |
| 2026-07-27 | 79.48x |
| 2026-07-24 | 77.33x |
| 2026-07-23 | 81.18x |
| 2026-07-22 | 83.33x |
| 2026-07-21 | 84.41x |
| 2026-07-20 | 82.56x |
| 2026-07-17 | 84.26x |
| 2026-07-16 | 79.33x |
| 2026-07-15 | 83.02x |
| 2026-07-14 | 80.41x |
| 2026-07-13 | 81.48x |
| 2026-07-10 | 82.72x |
| 2026-07-09 | 84.72x |
| 2026-07-08 | 81.64x |
| 2026-07-07 | 83.33x |
| 2026-07-06 | 81.33x |
| 2026-07-02 | 82.41x |
| 2026-07-01 | 79.02x |
| 2026-06-30 | 78.25x |
| 2026-06-29 | 74.09x |
| 2026-06-26 | 73.79x |
| 2026-06-25 | 72.40x |
| 2026-06-24 | 70.55x |
| 2026-06-23 | 72.56x |
| 2026-06-22 | 71.32x |
| 2026-06-18 | 66.09x |
| 2026-06-17 | 64.86x |
| 2026-06-16 | 63.63x |
| 2026-06-15 | 63.93x |
| 2026-06-12 | 63.32x |
| 2026-06-11 | 64.09x |
| 2026-06-10 | 59.93x |
| 2026-06-09 | 63.01x |
| 2026-06-08 | 63.93x |
| 2026-06-05 | 63.93x |
| 2026-06-04 | 69.32x |
| 2026-06-03 | 64.86x |
| 2026-06-02 | 68.09x |
| 2026-06-01 | 63.63x |
| 2026-05-29 | 66.86x |
| 2026-05-28 | 67.17x |
| 2026-05-27 | 67.32x |
| 2026-05-26 | 66.24x |
| 2026-05-22 | 66.40x |
| 2026-05-21 | 66.71x |
| 2026-05-20 | 66.55x |
| 2026-05-19 | 65.32x |
| 2026-05-18 | 64.55x |
| 2026-05-15 | 66.40x |
| 2026-05-14 | 70.71x |
| 2026-05-13 | 75.17x |
| 2026-05-12 | 71.94x |
| 2026-05-11 | 73.02x |
| 2026-05-08 | 72.71x |
| 2026-05-07 | 73.90x |
| 2026-05-06 | 72.64x |
| 2026-05-05 | 72.17x |
| 2026-05-04 | 68.72x |
| 2026-05-01 | 66.84x |
| 2026-04-30 | 65.75x |
| 2026-04-29 | 67.78x |
| 2026-04-28 | 63.86x |
| 2026-04-27 | 66.84x |
| 2026-04-24 | 65.12x |
| 2026-04-23 | 69.04x |
| 2026-04-22 | 66.53x |
| 2026-04-21 | 63.08x |
| 2026-04-20 | 64.33x |
| 2026-04-17 | 64.33x |
| 2026-04-16 | 60.10x |
| 2026-04-15 | 59.32x |
| 2026-04-14 | 59.16x |
| 2026-04-13 | 58.85x |
| 2026-04-10 | 61.04x |
| 2026-04-09 | 61.67x |
| 2026-04-08 | 59.63x |
| 2026-04-07 | 56.50x |
| 2026-04-06 | 57.28x |
| 2026-04-02 | 63.55x |
| 2026-04-01 | 62.61x |
| 2026-03-31 | 56.50x |
| 2026-03-30 | 52.42x |
| 2026-03-27 | 52.89x |
| 2026-03-26 | 52.89x |
| 2026-03-25 | 53.99x |
| 2026-03-24 | 49.44x |
| 2026-03-23 | 53.83x |
| 2026-03-20 | 55.56x |
| 2026-03-19 | 56.34x |
| 2026-03-18 | 55.09x |
| 2026-03-17 | 58.54x |
| 2026-03-16 | 56.34x |
| 2026-03-13 | 53.21x |
| 2026-03-12 | 52.74x |
| 2026-03-11 | 54.15x |
| 2026-03-10 | 55.24x |
| 2026-03-09 | 50.85x |
| 2026-03-06 | 45.68x |
| 2026-03-05 | 46.62x |
| 2026-03-04 | 46.31x |
| 2026-03-03 | 45.37x |
| 2026-03-02 | 45.53x |
| 2026-02-27 | 42.70x |
| 2026-02-26 | 22.92x |
| 2026-02-25 | 24.32x |
| 2026-02-24 | 24.71x |
| 2026-02-23 | 23.85x |
| 2026-02-20 | 23.78x |
| 2026-02-19 | 23.70x |
| 2026-02-18 | 23.23x |
| 2026-02-17 | 23.93x |
| 2026-02-13 | 23.39x |
| 2026-02-12 | 24.71x |
| 2026-02-11 | 24.94x |
| 2026-02-10 | 26.97x |
| 2026-02-09 | 27.28x |
| 2026-02-06 | 26.35x |
| 2026-02-05 | 24.94x |
| 2026-02-04 | 26.11x |
| 2026-02-03 | 25.57x |
| 2026-02-02 | 26.66x |
| 2026-01-30 | 25.88x |
| 2026-01-29 | 25.26x |
| 2026-01-28 | 25.88x |
| 2026-01-27 | 28.68x |
| 2026-01-26 | 28.29x |
| 2026-01-23 | 33.59x |
| 2026-01-22 | 33.82x |
| 2026-01-21 | 32.97x |
| 2026-01-20 | 33.04x |
| 2026-01-16 | 18.95x |
| 2026-01-15 | 19.34x |
| 2026-01-14 | 19.88x |
| 2026-01-13 | 19.65x |
| 2026-01-12 | 19.26x |
| 2026-01-09 | 19.10x |
| 2026-01-08 | 19.41x |
| 2026-01-07 | 19.41x |
| 2026-01-06 | 19.18x |
| 2026-01-05 | 19.18x |
| 2026-01-02 | 20.97x |
| 2025-12-31 | 21.98x |
| 2025-12-30 | 21.13x |
| 2025-12-29 | 21.98x |
| 2025-12-26 | 22.14x |
| 2025-12-24 | 22.22x |
| 2025-12-23 | 21.13x |
| 2025-12-22 | 22.45x |
| 2025-12-19 | 23.00x |
| 2025-12-18 | 22.53x |
| 2025-12-17 | 22.14x |
| 2025-12-16 | 23.54x |
| 2025-12-15 | 23.23x |
| 2025-12-12 | 23.85x |
| 2025-12-11 | 24.71x |
| 2025-12-10 | 24.01x |
| 2025-12-09 | 23.54x |
| 2025-12-08 | 24.09x |
| 2025-12-05 | 21.28x |
| 2025-12-04 | 21.98x |
| 2025-12-03 | 20.19x |
| 2025-12-02 | 19.57x |
| 2025-12-01 | 18.87x |
| 2025-11-28 | 20.58x |
| 2025-11-26 | 20.97x |
| 2025-11-25 | 19.80x |
| 2025-11-24 | 19.96x |
| 2025-11-21 | 18.09x |
| 2025-11-20 | 17.31x |
| 2025-11-19 | 17.70x |
| 2025-11-18 | 17.93x |
| 2025-11-17 | 17.62x |
| 2025-11-14 | 18.17x |
| 2025-11-13 | 16.61x |
| 2025-11-12 | 17.31x |
| 2025-11-11 | 16.45x |
| 2025-11-10 | 15.13x |
| 2025-11-07 | 16.61x |
| 2025-11-06 | 15.20x |
| 2025-11-05 | 15.13x |
| 2025-11-04 | 15.86x |
| 2025-11-03 | 17.32x |
| 2025-10-31 | 17.03x |
| 2025-10-30 | 16.81x |
| 2025-10-29 | 15.71x |
| 2025-10-28 | 16.08x |
| 2025-10-27 | 15.71x |
| 2025-10-24 | 14.33x |
| 2025-10-23 | 15.13x |
| 2025-10-22 | 15.13x |
| 2025-10-21 | 16.00x |
| 2025-10-20 | 13.30x |
| 2025-10-17 | 12.50x |
| 2025-10-16 | 13.60x |
| 2025-10-15 | 12.72x |
| 2025-10-14 | 11.84x |
| 2025-10-13 | 12.57x |
| 2025-10-10 | 12.28x |
| 2025-10-09 | 12.87x |
| 2025-10-08 | 12.50x |
| 2025-10-07 | 12.06x |
| 2025-10-06 | 12.50x |
| 2025-10-03 | 12.21x |
| 2025-10-02 | 12.06x |
| 2025-10-01 | 12.28x |
| 2025-09-30 | 12.50x |
| 2025-09-29 | 12.65x |
| 2025-09-26 | 13.16x |
| 2025-09-25 | 12.28x |
| 2025-09-24 | 12.28x |
| 2025-09-23 | 11.99x |
Showing the most recent 260 of 2,236 data points. The chart above shows the full history.
